Alternatives Split Wide as Semis Surge

Alternatives remained highly split, led by semiconductors while bitcoin stayed deeply negative despite a sharp rebound.

Semiconductors took the lead in alternatives and did so decisively. VanEck Semiconductor ETF (SMH) set the pace at 12.2%, up 7.1 points. It extended gains and overtook a field that remained sharply split. Global X U.S. Infrastructure Development ETF (PAVE) followed at 9.0%, up 4.0 points, and iShares Global Clean Energy ETF (ICLN) reached 9.2%, up 3.6 points. That halted momentum decay. The laggard remained iShares Bitcoin Trust (IBIT) at -18.8%, up 6.7 points, still deep in negative territory despite the strongest rebound outside semiconductors. iShares US Technology ETF (IYW) improved to -3.7%, up 3.5 points. It was recovering from weak levels but still near a 1-year low in its own history.

Breadth stood at 61.5% in the alternatives space, but dispersion (the spread in momentum readings across ETFs within the group) was the defining feature. The gap between SMH at 12.2%, up 7.1 points, and IBIT at -18.8%, up 6.7 points, was 31.0 points. That left the group in a mixed regime rather than a unified advance. iShares MSCI USA Momentum Factor ETF (MTUM) marked the most important transition, moving to 2.6%, up 5.2 points. It crossed into a positive regime while also increasing sensitivity to broad market moves.

Breakouts appeared in VanEck Semiconductor ETF (SMH) at 12.2%, up 7.1 points, Global X U.S. Infrastructure Development ETF (PAVE) at 9.0%, up 4.0 points, and iShares MSCI USA Momentum Factor ETF (MTUM) at 2.6%, up 5.2 points. Breakdowns hit iShares Preferred and Income Securities ETF (PFF) at -1.4%, up 0.2 points, iShares MSCI USA Min Volatility ETF (USMV) at -1.6%, down 1.7 points, and iShares Biotechnology ETF (IBB) at -1.7%, down 2.0 points. Sign flips came from iShares MSCI USA Momentum Factor ETF (MTUM) at 2.6%, up 5.2 points, First Trust Long/Short Equity ETF (FTLS) at 1.3%, up 1.9 points, iShares MSCI USA Min Volatility ETF (USMV) at -1.6%, down 1.7 points, and iShares Biotechnology ETF (IBB) at -1.7%, down 2.0 points. For SMH, the advance was accompanied by velocity exhaustion (a slowdown in the pace of weekly momentum gains). That was a reminder that leadership was strong but increasingly crowded.

‍

Romain Gandon

CEO, Quantlake

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice.

‍